Cosentyx (secukinumab) is a medication used to treat various conditions such as psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis. While side effects can occur in children as well as adults, it is important to note that the safety and effectiveness of Cosentyx in pediatric patients have not been established. Therefore, the use of Cosentyx in children is generally not recommended unless specifically prescribed by a healthcare provider after careful consideration of the risks and benefits.

Common side effects of Cosentyx in adults may include upper respiratory infections, diarrhea, and reactions at the injection site. Serious side effects such as infections and allergic reactions are also possible. It is crucial for healthcare providers to closely monitor pediatric patients if Cosentyx is prescribed to them to detect any potential side effects early on.

In conclusion, while Cosentyx has been shown to be effective in treating certain conditions in adults, its safety profile in children is not well-established. Therefore, any decision to use Cosentyx in pediatric patients should be made cautiously by healthcare providers, weighing the potential benefits against the possible risks.

Sources:
[1] drugpatentwatch.com
[2] mayoclinic.org
[3] cosentyx.com